Quantinuum, NVIDIA Corporation, and Pfizer Inc Transformer Models Now Generate Quantum Circuits for Molecular Models

Researchers at Quantinuum, NVIDIA Corporation, and Pfizer Inc. have developed ADAPT-GQE, a generative AI framework that accelerates the creation of quantum circuits for complex molecular modeling. The work demonstrates reductions in circuit generation time of one order of magnitude relative to ADAPT-VQE, while maintaining comparable or improved accuracy of preparing molecular ground states. Imipramine, a well-established tricyclic antidepressant, serves as a representative and challenging target for this framework, demonstrating a pathway toward applying quantum computing to both materials science and pharmaceutical development. The team executed generated circuits on Quantinuum’s Helios-1 hardware, a milestone for AI-generated quantum chemistry circuits on advanced quantum hardware and…